Eye-drop vaccine containing copolymer 1 for therapeutic immunization
CA 2512735 C · Owner: Fulga, Valentin · Inventors: Fulga, Valentin; Eisenbach-Schwartz, Michal; Bakalash, Sharon
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides an eye-drop vaccine for therapeutic immunization of a mammal comprising Copolymer 1, a Copolymer 1-related peptide or a Copolymer 1-, related polypeptide for treating neuronal degeneration caused by an injury or disease, disorder or condition in the central nervous system (CNS) or peripheral nervous system (PNS), for preventing or inhibiting neuronal secondary degeneration which may otherwise follow primary injury in the CNS for promoting nerve regeneration in the CNS or in the PNS after an injury disease, disorder or condition or for protecting CNS and PNS cells from glutamate toxicity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 6, 2004 and granted March 8, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 6, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 6, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.